Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion proteins

Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion proteins

US Patent 12168036 · Granted Dec 17, 2024

Estimated economic value: $79,808,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activin a antibody formulations and methods of use thereof2025
Devices and methods for overfilling drug containers2025
Methods for predicting and modulating glycation of a protein2025
VEGF antagonist formulations suitable for intravitreal administration2025
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2024
Devices and methods for overfilling drug containers2024
VEGF antagonist formulations suitable for intravitreal administration2023
Devices and methods for overfilling drug containers2023
High concentration VEGF receptor fusion protein containing formulations2021
High concentration VEGF receptor fusion protein containing formulations2021
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2021
VEGF antagonist formulations suitable for intravitreal administration2021